SK286339B6 - Dry powder formulation containing amoxicillin, clavulanic acid and cellulose - Google Patents
Dry powder formulation containing amoxicillin, clavulanic acid and cellulose Download PDFInfo
- Publication number
- SK286339B6 SK286339B6 SK84-2001A SK842001A SK286339B6 SK 286339 B6 SK286339 B6 SK 286339B6 SK 842001 A SK842001 A SK 842001A SK 286339 B6 SK286339 B6 SK 286339B6
- Authority
- SK
- Slovakia
- Prior art keywords
- formulation
- cellulose
- formulations
- microcrystalline cellulose
- clavulanic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9815532.8A GB9815532D0 (en) | 1998-07-17 | 1998-07-17 | Pharmaceutical suspension formulation |
| PCT/GB1999/002295 WO2000003695A1 (en) | 1998-07-17 | 1999-07-15 | Pharmaceutical suspension formulation comprising amoxycillin, clavulanic acid and cellulose |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK842001A3 SK842001A3 (en) | 2001-09-11 |
| SK286339B6 true SK286339B6 (en) | 2008-07-07 |
Family
ID=10835666
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK84-2001A SK286339B6 (en) | 1998-07-17 | 1999-07-15 | Dry powder formulation containing amoxicillin, clavulanic acid and cellulose |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6511972B1 (uk) |
| EP (1) | EP1098633A1 (uk) |
| AU (1) | AU762840B2 (uk) |
| CZ (1) | CZ296003B6 (uk) |
| GB (1) | GB9815532D0 (uk) |
| HR (1) | HRPK20010048B1 (uk) |
| HU (1) | HUP0103015A3 (uk) |
| PL (1) | PL194393B1 (uk) |
| RU (1) | RU2205639C2 (uk) |
| SK (1) | SK286339B6 (uk) |
| UA (1) | UA73720C2 (uk) |
| WO (1) | WO2000003695A1 (uk) |
| YU (1) | YU3101A (uk) |
| ZA (1) | ZA200100463B (uk) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR004510A1 (es) | 1995-09-07 | 1998-12-16 | Smithkline Beecham Plc | Composiciones que comprenden amoxicilina y clavulanato, procedimientos para su preparacion y el uso de las composiciones para la fabricacion de unmedicamento |
| US7250176B1 (en) * | 1999-04-13 | 2007-07-31 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection |
| GB2365337A (en) * | 1999-04-13 | 2002-02-20 | Beecham Pharma | Amoxycillin and potassium clavulanate high dosage regimen |
| US6294199B1 (en) | 1999-04-13 | 2001-09-25 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising administering amoxycillin |
| NL1014915C2 (nl) * | 1999-04-13 | 2001-02-12 | Beecham Pharm Pte Ltd | Nieuwe behandelingsmethode. |
| US6878386B1 (en) | 1999-04-13 | 2005-04-12 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate |
| PT1078627E (pt) * | 1999-08-20 | 2006-10-31 | Glaxosmithkline Lab Sas | Formulacao farmaceutica compreendendo amoxicilina e clavulanato |
| FR2797588B1 (fr) * | 1999-08-20 | 2003-08-01 | Smithkline Beecham Lab | Formulation pharmaceutique a base d'amoxycilline et de clavulanate |
| SI20411A (sl) * | 1999-12-22 | 2001-06-30 | LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. | Vodotopni praški za peroralno raztopino in njihova uporaba |
| US6756057B2 (en) | 2000-10-12 | 2004-06-29 | Beecham Pharmaceuticals (Pte) Limited | Amoxicillin and potassium clavulanate dosage form |
| MXPA03006565A (es) * | 2001-01-23 | 2005-07-29 | Gador Sa | Composicion comprendiendo bisfosfonatos para la prevencion y/o tratamiento de enfermedades metabolicas de huesos, proceso para preparar tal composicion y el uso de la misma. |
| JP2006527726A (ja) * | 2003-06-16 | 2006-12-07 | グラクソ グループ リミテッド | アモキシシリンおよびクラブラン酸塩を含む医薬製剤 |
| US20080242725A1 (en) * | 2004-03-01 | 2008-10-02 | Janez Kerc | Pharmaceutical Composition |
| TR201000686A1 (tr) * | 2010-01-29 | 2011-08-22 | B�Lg�� Mahmut | Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@ |
| TR201000687A1 (tr) * | 2010-01-29 | 2011-08-22 | Bi̇lgi̇ç Mahmut | Aktif madde olarak sefiksim ve klavulanik asit içeren efervesan formülasyonlar |
| WO2013173803A2 (en) * | 2012-05-17 | 2013-11-21 | Michael Spector | Formulations of amoxicillin and clavulanate potassium and methods for using same |
| WO2013173808A2 (en) * | 2012-05-17 | 2013-11-21 | Michael Spector | Methods for use of lower dose compositions of amoxicillin and clavulanate potassium and devices for use |
| US9254261B2 (en) | 2014-03-03 | 2016-02-09 | Sandoz Ag | Stable quick dissolving dosage form comprising amoxicillin and clavulanic acid |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DZ2028A1 (fr) | 1995-05-03 | 2002-10-23 | Smithkline Beecham Plc | Médicaments destinés au traitement d'infections bactériennes en pédiatrie. |
| JPH11510811A (ja) | 1995-08-12 | 1999-09-21 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 医薬処方 |
| DE69815833T2 (de) * | 1997-02-14 | 2004-05-19 | Laboratoire Glaxosmithkline S.A.S. | Amoxicillin und clavulanat enthaltende arzneizubereitungen |
| DE19706978A1 (de) * | 1997-02-21 | 1998-08-27 | Ulrich Dr Posanski | Kombinationspräparat für oral applizierbare Antibiotika |
-
1998
- 1998-07-17 GB GBGB9815532.8A patent/GB9815532D0/en not_active Ceased
-
1999
- 1999-07-15 RU RU2001102491/14A patent/RU2205639C2/ru not_active IP Right Cessation
- 1999-07-15 UA UA2001010380A patent/UA73720C2/uk unknown
- 1999-07-15 SK SK84-2001A patent/SK286339B6/sk not_active IP Right Cessation
- 1999-07-15 WO PCT/GB1999/002295 patent/WO2000003695A1/en active IP Right Grant
- 1999-07-15 EP EP99934854A patent/EP1098633A1/en not_active Withdrawn
- 1999-07-15 CZ CZ2001217A patent/CZ296003B6/cs not_active IP Right Cessation
- 1999-07-15 AU AU50497/99A patent/AU762840B2/en not_active Ceased
- 1999-07-15 PL PL99345564A patent/PL194393B1/pl not_active IP Right Cessation
- 1999-07-15 HU HU0103015A patent/HUP0103015A3/hu unknown
- 1999-07-15 YU YU3101A patent/YU3101A/sh unknown
- 1999-07-15 US US09/743,998 patent/US6511972B1/en not_active Expired - Lifetime
-
2001
- 2001-01-17 ZA ZA200100463A patent/ZA200100463B/en unknown
- 2001-01-17 HR HR20000029A patent/HRPK20010048B1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PL194393B1 (pl) | 2007-05-31 |
| HUP0103015A3 (en) | 2003-01-28 |
| AU5049799A (en) | 2000-02-07 |
| CZ296003B6 (cs) | 2005-12-14 |
| UA73720C2 (en) | 2005-09-15 |
| EP1098633A1 (en) | 2001-05-16 |
| WO2000003695A1 (en) | 2000-01-27 |
| HRP20010048A2 (en) | 2002-02-28 |
| GB9815532D0 (en) | 1998-09-16 |
| SK842001A3 (en) | 2001-09-11 |
| US6511972B1 (en) | 2003-01-28 |
| PL345564A1 (en) | 2001-12-17 |
| YU3101A (sh) | 2003-10-31 |
| HUP0103015A2 (hu) | 2001-12-28 |
| RU2205639C2 (ru) | 2003-06-10 |
| CZ2001217A3 (cs) | 2001-08-15 |
| HRPK20010048B1 (en) | 2003-04-30 |
| ZA200100463B (en) | 2001-09-04 |
| AU762840B2 (en) | 2003-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK286339B6 (en) | Dry powder formulation containing amoxicillin, clavulanic acid and cellulose | |
| EP1370247B1 (en) | Taste masked pharmaceutical compositions | |
| US6214359B1 (en) | Use of a combination of amoxycillin and clavulanate in the manufacture of a medicament for the treatment drug-resistant Streptococcus pneumoniae | |
| US5599557A (en) | Stable hydrated cephalosporin dry powder for oral suspension formulation | |
| JP3501289B2 (ja) | 医薬処方 | |
| SK146297A3 (en) | Composition comprising amoxycillin and clavulanic acid | |
| US20140171401A1 (en) | Novel pharmaceutical formulation of cefixime for enhanced bioavailability | |
| US9233112B2 (en) | Pharmaceutical compositions of cefixime | |
| US20040191326A1 (en) | Taste-masking vehicle for coated oxazolidinone particles | |
| US9241905B2 (en) | Pharmaceutical compositions of Cefixime | |
| US20020099044A1 (en) | Composition comprising amoxycillin and clavulanic acid | |
| EP3799861B1 (en) | Pediatric suspension formulation | |
| SI20058A (sl) | Farmacevtske oblike | |
| CZ11407U1 (cs) | Farmaceutický prostředek uzpůsobený pro pediatrické podávání |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20100715 |